Suppr超能文献

新辅助放化疗后经肛门内镜显微手术治疗局部晚期腹膜外直肠癌。

Transanal endoscopic microsurgery after neoadjuvant radiochemotherapy for locally advanced extraperitoneal rectal cancer.

作者信息

Rizzo G, Zaccone G, Magnocavallo M, Mattana C, Pafundi D P, Gambacorta M A, Valentini V, Coco C

机构信息

Polo Apparato Digerente e Sistema Endocrino-Metabolico - Area Chirurgica Addominale, Fondazione Policlinico Universitario "Agostino Gemelli" - Università Cattolica del Sacro Cuore, Rome, Italy.

Polo Apparato Digerente e Sistema Endocrino-Metabolico - Area Chirurgica Addominale, Fondazione Policlinico Universitario "Agostino Gemelli" - Università Cattolica del Sacro Cuore, Rome, Italy.

出版信息

Eur J Surg Oncol. 2017 Aug;43(8):1488-1493. doi: 10.1016/j.ejso.2017.05.011. Epub 2017 May 25.

Abstract

PURPOSE

The aim of this study is to provide a prospective analysis of post-operative and oncological outcomes in patients affected by locally advanced rectal cancer (LARC), who obtained a major/complete clinical response after pre-operative radio-chemotherapy (RCT) and were treated with local excision (LE) by trans-anal endoscopic microsurgery (TEM) to confirm a pathological complete response (pCR) after to neo-adjuvant RCT.

METHODS

All patients with LARC treated by pre-operative RCT and full-thickness LE by TEM (2000-2014) were included in the study. If the pathological analysis confirmed near complete or pCR, intensive follow up was proposed. If the pathological response was incomplete, a radical resection with TME was proposed. Post-operative (according to Clavien's classification), functional and long-term oncological outcome were analyzed.

RESULTS

36 patients were treated by TEM. The median post-operative hospital stay was 5 days. The post-operative morbidity was 41.6% (no grade ≥3). At pathological analysis, 23 specimens were ypT0 TRG1, and 4 were ypT1 TRG2. In 9 cases (ypT>1 and/or TRG>2), radical surgery with TME was proposed but 3 refused it. Median follow-up was 68 months. One local recurrence and 4 distant metastases occurred. The 5-yr actuarial local control, overall survival and disease-free survival were 96.0%, 92.0% and 82.8%.

CONCLUSIONS

In case of major or complete clinical response of LARC after pre-operative RCT, LE by TEM can be used to confirm the pathological response. This avoids the necessity of radical surgery and, in our experience, this approach seems to guarantee oncological safety with the functional advantages of an organ-sparing procedure.

摘要

目的

本研究旨在对局部晚期直肠癌(LARC)患者的术后及肿瘤学结局进行前瞻性分析。这些患者在术前放化疗(RCT)后获得了主要/完全临床缓解,并通过经肛门内镜显微手术(TEM)进行局部切除(LE),以确认新辅助RCT后的病理完全缓解(pCR)。

方法

本研究纳入了所有接受术前RCT及TEM全层LE治疗的LARC患者(2000 - 2014年)。如果病理分析证实接近完全缓解或pCR,则建议进行强化随访。如果病理反应不完全,则建议进行TME根治性切除。分析术后(根据Clavien分类)、功能及长期肿瘤学结局。

结果

36例患者接受了TEM治疗。术后中位住院时间为5天。术后发病率为41.6%(无≥3级)。病理分析显示,23个标本为ypT0 TRG1,4个为ypT1 TRG2。9例(ypT>1和/或TRG>2)建议行TME根治性手术,但3例拒绝。中位随访时间为68个月。发生1例局部复发和4例远处转移。5年局部控制率、总生存率和无病生存率分别为96.0%、92.0%和82.8%。

结论

对于术前RCT后LARC出现主要或完全临床缓解的情况,TEM进行LE可用于确认病理反应。这避免了根治性手术的必要性,并且根据我们的经验,这种方法似乎在保证肿瘤学安全性的同时具有保留器官手术的功能优势。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验